SMARCA2抗体 [HMV337] HistoMAX™

IHC-P analysis of human anal canal squamous cell carcinoma (SCC) tissue using GTX640917 SMARCA2 antibody [HMV337] HistoMAX™.
Squamous cell carcinoma with strong SMARCA2 immunostaining of tumor cells.

IHC-P analysis of human malignant melanoma from skin tissue using GTX640917 SMARCA2 antibody [HMV337] HistoMAX™.
Malignant melanoma showing a faint SMARCA2 staining in only about 60% of tumor cells.

IHC-P analysis of human warthin tumor (WT) from salivary gland tissue using GTX640917 SMARCA2 antibody [HMV337] HistoMAX™.
Warthin tumor  showing a strong SMARCA2 immunostaining of tumor cells.

IHC-P analysis of human high-grade serous ovarian cancer (HGSOC) tissue using GTX640917 SMARCA2 antibody [HMV337] HistoMAX™.
A complete loss of SMARCA2 expression.

IHC-P analysis of human muscle-invasive bladder cancer (MIBC) tissue using GTX640917 SMARCA2 antibody [HMV337] HistoMAX™.
A strong SMARCA2 positivity of tumor cells.

IHC-P analysis of human testis tissue using GTX640917 SMARCA2 antibody [HMV337] HistoMAX™.
A distinct nuclear SMARCA2 staining in all intratubular cells except Sertoli cells.